Amyotrophic Lateral Sclerosis represents a global public health challenge as the premier adult-onset motor neuron disease
Standard Epidemiological Metrics
ALS predominantly presents in the 5th or 6th decade of life
Global Prevalence: 3 to 5 cases per 100,000 population
. Annual Incidence: Approximately 2 cases per 100,000 individuals per year
. Younger Onset: In younger age groups, incidence drops to 1–3 cases per 500,000 per year
.
Global ALS Metrics:
┌────────────────────────────────────────────────────────┐
│ Prevalence: 3–5 / 100,000 │
│ Annual Incidence: 2 / 100,000 per year │
│ Male : Female Ratio: 1.6 : 1 │
└────────────────────────────────────────────────────────┘
High-Incidence Geographic Foci
While the majority of ALS cases worldwide are sporadic and uniform, historical epidemiology identified localized endemic foci exhibiting incidence rates up to 50 times higher than global baselines
Guam: High prevalence among the Chamorro population
. Kii Peninsula of Japan: High-density clusters of ALS and parkinsonism-dementia complex
. West New Guinea: Unique epidemiological pockets demonstrating elevated motor neuron degeneration
.
Sporadic vs. Inherited Patterns
Epidemiologically, sporadic cases (SALS) vasty outnumber inherited or familial cases (FALS)
Key Takeaways
Typical onset occurs in the 5th or 6th decade, with a 1.6:1 male predominance
. Global incidence stands at ~2 per 100,000 per year
. High-incidence clusters (up to 50x) include Guam, the Kii Peninsula, and New Guinea
.